del Carmen M - Search Results

1

Na YJ, Farley J, Zeh A, del Carmen M, Penson R, Birrer MJ. Na YJ, et al. Among authors: del carmen m. Int J Gynecol Cancer. 2009 Dec;19 Suppl 2:S21-9. doi: 10.1111/IGC.0b013e3181c2aeb5. Int J Gynecol Cancer. 2009. PMID: 19955910 Review.

2

Phase II trial of anastrozole in women with asymptomatic müllerian cancer.

del Carmen MG, Fuller AF, Matulonis U, Horick NK, Goodman A, Duska LR, Penson R, Campos S, Roche M, Seiden MV. del Carmen MG, et al. Gynecol Oncol. 2003 Dec;91(3):596-602. doi: 10.1016/j.ygyno.2003.08.021. Gynecol Oncol. 2003. PMID: 14675683 Clinical Trial.

3

Carcinosarcoma of the ovary: a review of the literature.

del Carmen MG, Birrer M, Schorge JO. del Carmen MG, et al. Gynecol Oncol. 2012 Apr;125(1):271-7. doi: 10.1016/j.ygyno.2011.12.418. Epub 2011 Dec 8. Gynecol Oncol. 2012. PMID: 22155675 Review.

4

Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review.

Growdon WB, Rauh-Hain JJ, Cordon A, Garrett L, Schorge JO, Goodman A, Boruta DM, Horowitz NS, del Carmen MG. Growdon WB, et al. Among authors: del carmen mg. Int J Gynecol Cancer. 2012 Mar;22(3):417-24. doi: 10.1097/IGC.0b013e31823c6e36. Int J Gynecol Cancer. 2012. PMID: 22237383

5

Clear cell carcinoma of the ovary: a review of the literature.

del Carmen MG, Birrer M, Schorge JO. del Carmen MG, et al. Gynecol Oncol. 2012 Sep;126(3):481-90. doi: 10.1016/j.ygyno.2012.04.021. Epub 2012 Apr 21. Gynecol Oncol. 2012. PMID: 22525820 Review.

6

Uterine papillary serous cancer: a review of the literature.

del Carmen MG, Birrer M, Schorge JO. del Carmen MG, et al. Gynecol Oncol. 2012 Dec;127(3):651-61. doi: 10.1016/j.ygyno.2012.09.012. Epub 2012 Sep 20. Gynecol Oncol. 2012. PMID: 23000148 Review.

7

Uterine leiomyosarcoma: an updated series.

Rauh-Hain JA, Oduyebo T, Diver EJ, Guseh SH, George S, Muto MG, del Carmen MG. Rauh-Hain JA, et al. Int J Gynecol Cancer. 2013 Jul;23(6):1036-43. doi: 10.1097/IGC.0b013e31829590dc. Int J Gynecol Cancer. 2013. PMID: 23714705

8

Pushing the bar in treatment of cervical cancer: what can comprehensive cancer centers do on their own?

Dizon DS, Ambrosio AJ, Feltmate C, Wright AA, Campos SM, Viswanathan A; Cervical Cancer Special Interest Group of Dana Farber/Harvard Comprehensive Cancer Center Gynecologic Cancer Management Team. Dizon DS, et al. Gynecol Oncol. 2013 Nov;131(2):464-6. doi: 10.1016/j.ygyno.2013.08.002. Epub 2013 Aug 9. Gynecol Oncol. 2013. PMID: 23938373 No abstract available.

9

Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.

Rauh-Hain JA, Guseh SH, Esselen KM, Growdon WB, Schorge JO, Horowitz NS, Krasner CN, del Carmen MG, Birrer MJ, Dizon DS. Rauh-Hain JA, et al. Among authors: del carmen mg. Int J Gynecol Cancer. 2013 Sep;23(7):1219-25. doi: 10.1097/IGC.0b013e31829f17c9. Int J Gynecol Cancer. 2013. PMID: 23975042

10

Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.

Rauh-Hain JA, Hinchcliff EM, Oduyebo T, Worley MJ Jr, Andrade CA, Schorge JO, George S, Muto MG, del Carmen MG. Rauh-Hain JA, et al. Among authors: del carmen mg. Int J Gynecol Cancer. 2014 Oct;24(8):1434-40. doi: 10.1097/IGC.0000000000000221. Int J Gynecol Cancer. 2014. PMID: 25248114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters